[Corrigendum] Inhibition of Rac1 reverses enzalutamide resistance in castration‑resistant prostate cancer

Chen,Xiaoliang; Yin,Lili; Qiao,Gan; Li,Yanhua; Li,Baoyuan; Bai,Yunfeng; Feng,Feng

doi:10.3892/ol.2026.15523

May-2026 Volume 31 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2026 Volume 31 Issue 5

Full Size Image

Correction Open Access

[Corrigendum] Inhibition of Rac1 reverses enzalutamide resistance in castration‑resistant prostate cancer

Authors:
- Xiaoliang Chen
- Lili Yin
- Gan Qiao
- Yanhua Li
- Baoyuan Li
- Yunfeng Bai
- Feng Feng
View Affiliations / Copyright

Affiliations: School of Medicine, Shanxi Datong University, Datong, Shanxi 037009, P.R. China, School of Life Sciences, Shanxi Datong University, Datong, Shanxi 037009, P.R. China, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Department of Chemistry, School of Chemistry and Environmental Engineering, Shanxi Datong University, Datong, Shanxi 037009, P.R. China

Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 169
|
Published online on: March 11, 2026

https://doi.org/10.3892/ol.2026.15523
Expand metrics +

Article

Oncol Lett 20: [Related article:] 2997–3005, 2020; DOI: 10.3892/ol.2020.11823

Following the publication of the above article, an interested reader drew to the authors' attention that, for the Transwell migration assay experiments shown in Fig. 3A on p. 3001, the sh-Ctl/DMSO and sh-Ct/Enza data panels appeared to contain an overlapping section of data, such that these data panels were apparently derived from the same original source where the results of different experiments were intended to have been portrayed.

Figure 3.

Knockdown of Rac1 attenuates migration and invasion of Enza-resistant PCa cells. (A-D) MR49F cells were depleted of Rac1 using an shRNA lentivirus and then treated with or without 10 µM Enza followed by analysis of cell (A and B) migration and (C and D) invasion using Transwell assay at ×100 magnification. (B and D) Quantification of the number of (B) migration and the invasion (D) cells. (E) Western blotting was used to assess the mechanism of the enzalutamide-induced inhibitory effect on apoptosis and EMT. Data are presented as the mean ± SD of three independent experiments. *P<0.05, **P<0.01. Rac1, Ras-related C3 botulinum toxin substrate 1; shRNA, short hairpin RNA; Ctl, control; Enza, enzalutamide; ATF2, activated transcription factor 2.

The authors were able to consult their original data, and realized that this figure had inadvertently been assembled incorrectly. The revised version of Fig. 3, now showing the correct data for the sh-Ct/Enza panel, is shown on the next page. The authors regret that this error occurred in the original published version of this figure, although this did not grossly affect the results or the conclusions reported in this article. All the authors agree with the publication of this Corrigendum, and thank the Editor of Oncology Letters for allowing them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Inhibition of Rac1 reverses enzalutamide resistance in castration‑resistant prostate cancer

This article is mentioned in:

Article

Figure 3.

Related Articles